Assessment of PTAH and Troponin-I in Detecting Early Myocardial Infarction Postmortem
Journal of MedVerse Research & Practice · 2025
DOI: 10.65188/nurexus.1020 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of MedVerse Research & Practice, 2025. Verfasst von Vidhya R und 1 weiteren Autor:innen. Die Arbeit nennt 12 Literaturangaben.
Abstract (Originalsprache)
Introduction
Early detection of myocardial infarction (MI) in post-mortem heart samples is essential for understanding sudden cardiac deaths and evaluating the accuracy of diagnostic markers. Phosphotungstic Acid Hematoxylin (PTAH) staining and Cardiac Troponin I (cTnI) immunohistochemistry are promising techniques for identifying myocardial injury in post-mortem cases. This study aims to assess the effectiveness of PTAH and cTnI in detecting early myocardial infarction in post-mortem heart samples. Materials and Methods: This cross-sectional study included 82 post-mortem heart samples collected from the Department of Pathology, Government Medical College, Thiruvananthapuram. Samples were categorized into three histological groups based on the stage of myocardial infarction: early (Group 1), intermediate (Group 2), and late (Group 3). PTAH staining and cTnI immunohistochemistry were performed to assess myocardial injury. The relationship between histological stages and diagnostic markers was analysed using Chi-square tests.
Results
The study found that 67.1% of the samples had coronary artery disease (CAD). The majority of samples were in the intermediate stage (Group 2, 46.3%), followed by early (Group 1, 29.3%) and late (Group 3, 24.4%) infarction stages. PTAH staining showed positive results in 63.4% of cases, with a higher frequency of positive findings in early and intermediate stages. cTnI expression demonstrated a significant loss in early stages, with 57.3% showing moderate loss, while late stages exhibited milder reductions. A significant association was found between the histological stage of MI and cTnI loss (p = 0.01).
Conclusion
PTAH staining and cTnI immunohistochemistry are valuable diagnostic tools for identifying early myocardial infarction in post-mortem heart samples. cTnI, in particular, correlates strongly with the stage of myocardial infarction, making it a reliable marker for early detection in post-mortem diagnostics. Keywords: Early Myocardial Infarction, Postmortem Diagnosis, Phosphotungstic Acid Hematoxylin (PTAH), Cardiac Troponin I (cTnI)
Zitieren
APA
R, V., & Murthi, P. (2025). Assessment of PTAH and Troponin-I in Detecting Early Myocardial Infarction Postmortem. Journal of MedVerse Research & Practice. https://doi.org/10.65188/nurexus.1020
Vancouver
R V, Murthi P. Assessment of PTAH and Troponin-I in Detecting Early Myocardial Infarction Postmortem. Journal of MedVerse Research & Practice. 2025. doi:10.65188/nurexus.1020
BibTeX
@article{R2025,
author = {R, Vidhya and Murthi, Priya},
title = {Assessment of PTAH and Troponin-I in Detecting Early Myocardial Infarction Postmortem},
journal = {Journal of MedVerse Research & Practice},
year = {2025},
doi = {10.65188/nurexus.1020}
}
EUVIMED